BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25620163)

  • 1. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer.
    Swanick CW; Castle KO; Rechner LA; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
    Brachytherapy; 2015; 14(3):385-9. PubMed ID: 25620163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer.
    van Dyk S; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):860-5. PubMed ID: 24462382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
    Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
    Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix.
    Mahantshetty U; Khanna N; Swamidas J; Engineer R; Thakur MH; Merchant NH; Deshpande DD; Shrivastava S
    Radiother Oncol; 2012 Jan; 102(1):130-4. PubMed ID: 21885140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
    Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
    Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound.
    Van Dyk S; Narayan K; Fisher R; Bernshaw D
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):64-70. PubMed ID: 19250767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
    Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept.
    Nesvacil N; Schmid MP; Pötter R; Kronreif G; Kirisits C
    Brachytherapy; 2016; 15(6):839-844. PubMed ID: 27693172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
    Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
    Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
    Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility and interoperator reliability of obtaining images and measurements of the cervix and uterus with brachytherapy treatment applicators in situ using transabdominal ultrasound.
    van Dyk S; Garth M; Oates A; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
    Brachytherapy; 2016; 15(1):71-8. PubMed ID: 26614235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma.
    Rai B; Patel FD; Chakraborty S; Sharma SC; Kapoor R; Aprem AS
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e217-22. PubMed ID: 23517809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
    Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
    Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer.
    Cooper R; Brearley E; Hurmuz P; Musunuru HB; Richardson C; Swift S; Orton J; Bownes P
    Arch Gynecol Obstet; 2014 Dec; 290(6):1201-5. PubMed ID: 25001571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy.
    Beriwal S; Kim H; Coon D; Mogus R; Heron DE; Li X; Huq MS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):483-7. PubMed ID: 19423307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.